Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay?

Over the past decade, an increasing number of oncology medicines with indications for multiple cancer types have been delivering benefits to patients. To ensure these products reach patients, pricing and reimbursement systems have had to adapt to address the value assessment, time-to-access, afforda...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannah Armstrong, Angelina Petrova, Tim Wilsdon, Henriette Homoki, Alexander Roediger
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:https://www.mdpi.com/2001-6689/13/1/2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items